The 10K Annual report was released. No proxy statement yet.
Here are some select bits, FYI
BIO-TECHNOLOGY GENERAL CORP. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
December 31,
-----------------------
1998 1999
--------- ---------
ASSETS
Current Assets:
Cash and cash equivalents .......................... $ 9,431 $ 18,703
Short-term investments ............................. 37,602 68,547
Other receivables .................................. 15,968 579
Accounts receivable - trade ....................... 52,429 36,925
Inventories ........................................ 4,978 8,624
Deferred income taxes (Note 10) .................... 5,407 4,286
Prepaid expenses ................................... 344 220
--------- ---------
Total current assets ............................ 126,159 137,884
Accounts receivable - trade .......................... -- 2,443
Severance pay funded (Note 2) ........................ 2,233 2,369
Property and equipment, net (Note 3) ................. 9,442 18,938
Intangibles, net of accumulated amortization of
$4,303 in 1998 and $5,186 in 1999 .................. 1,728 993
Patents, net of accumulated amortization of $487
in 1998 and $643 in 1999 ........................... 404 429
Other assets ......................................... 2,629 1,589
--------- ---------
Total assets .................................... $ 142,595 $ 164,645
========= =========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Short-term bank loans .............................. $ 288 $ 20
Accounts payable ................................... 5,359 7,257
Other current liabilities (Note 8) ................. 10,153 11,151
--------- ---------
Total current liabilities ....................... 15,800 18,428
--------- ---------
Long-term liabilities (Note 2) ....................... 3,818 4,333
--------- ---------
Commitments and contingent liabilities (Note 7)
Stockholders' Equity (Notes 4 and 5):
Preferred stock - $.01 par value; 4,000,000
shares authorized; no shares issued ............. -- --
Common stock - $.01 par value; 150,000,000
shares authorized; issued: 51,934,000 in 1998
and 53,280,000 in 1999 .......................... 519 533
Capital in excess of par value ..................... 161,164 168,743
Accumulated deficit ................................ (36,396) (22,534)
Treasury stock at cost (83,000 shares) ............. (340) (340)
Accumulated other comprehensive loss ............... (1,970) (4,518)
--------- ---------
Total stockholders' equity ....................... 122,977 141,884
--------- ---------
Total liabilities and stockholders' equity ...... $ 142,595 $ 164,645
========= =========
Looks like the AR numbers are still quite high.
Down 32% (52M vs 37M), but still up there!
Jim |
